Burney CO Albireo Pharma, Inc. Transaction History

Burney CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$18.54 - $37.29 $147,875 - $297,425	-7,976 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$23.94 - $33.74 $190,945 - $269,110	7,976 New	7,976 $238,000
Q4 2021 Feb 11, 2022	SELL	$21.19 - $31.29 $169,011 - $249,569	-7,976 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$28.9 - $36.87 $26,010 - $33,183	900 Added 12.72%	7,976 $281,000
Q1 2021 May 13, 2021	BUY	$32.03 - $42.85 $32,030 - $42,850	1,000 Added 16.46%	7,076 $249,000
Q4 2020 Feb 11, 2021	BUY	$31.56 - $42.16 $191,758 - $256,164	6,076 New	6,076 $228,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Burney CO, based on Form 13F filings with the SEC.

Stay updated on Burney CO with notifications on news.